Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

West Midlands
23 May 2013 10:29



N1
23 May 2013 09:56



East Midlands
23 May 2013 09:48


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
I just wanted to say a big thank you for Zenopa's help in getting me my new job. Zenopa have been a fantastic support.
Lindsay, 2012

HIV cases 'could be cut by 95 per cent'

26 November 2008 00:00 in Industry related health news


The number of people being diagnosed with HIV could be reduced by 95 per cent within ten years, through voluntary testing and immediate treatment, it has been claimed.

According to the World Health Organisation (WHO) universal voluntary testing and antiretroviral treatment (ART) following positive diagnosis would see cases of the disease fall from 20 per 1,000 people to one in every 1,000.

Dr Reuben Granich and colleagues at the department of HIV/Aids at the organisation used mathematical modelling to explore the effect on the case reproduction number and long-term dynamics of the virus.

About three million people worldwide had received ART by the end of 2007, but an estimated 6.7 million were still in need of therapy.

Researchers found their studied strategy could greatly accelerate the transition from the current endemic phase, in which most adults with the virus are not receiving the treatment, to an elimination phase, in which most adults are on it within five years.

"Our model suggests that only universal voluntary HIV testing and immediate initiation of ART could reduce transmission to the point at which elimination might be feasible by 2020 for a generalised epidemic, such as that in South Africa," the authors wrote in the Lancet.

Other news stories from 26/11/2008

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd